We Sequence, You Discover

BGI was established in 1999 as part of the world's very first Human Genome Project (HGP). Since then, we have built up over 20 years of genomics experience and developed a wide range of expert sequencing solutions, supporting researchers across the world pursue discovery across a fascinating variety of research.

For us, there is no project too big or too small. Please get in touch for a no obligation discussion or a free quote


Contact Us

BGI Genomics Sequencing Solutions

BGI Genomics is a publicly listed commercial genomics company established in 1999. We provide a wide range of next generation sequencing services and bioinformatics services, and a broad portfolio of genetic tests to support medical institutions, research institutions, pharmaceutical companies and many other public and private partners.

Our business covers more than 100 countries and regions around the world, including more than 2,000 scientific research institutions and more than 2,300 medical institutions in China. We work with more than 3,000 institutions across Europe, North America and Asia Pacific. 

Our expertise and scale allow us to provide quality data at extremely competitive pricing. Please visit our website to learn more about our solutions or get in touch directly via the form below.

Why Work with Us

Over 20 years of commercial sequencing experience and expert support

Proprietary sequencing platforms offering unrivaled cost efficiency

Global presence and commitment to highest standards of data protection

Standard Sequencing Project Workflow


  • Prepare your samples with our expert guidance
  • We support projects across all human/plant/animal/microbial species


  • We build the relevant library to support your project
  • We can advise the optimum library type based on your needs


  • We sequence your sample on our proprietary sequencing platforms
  • We can advise what level of coverage is suitable for your project or research question


  • We deliver your data via any standard file formats
  • Bioinformatics support to help interpret your data is available as needed


Contact Us

Get Your Quote Today!

Our DNBSEQ™ Sequencing Technology

DNBSEQ™ is a proprietary sequencing technology, first developed by MGI's Complete Genomics subsidiary in Silicon Valley, and can offer advantages in terms of lower amplification error rates and much lower duplication rates for some sequencing applications. In addition, studies have shown the index hopping rate in DNBSEQ™ platforms can be much lower when compared to that of other platforms.